APOE ε 2 is associated with white matter hyperintensity volume in CADASIL

Journal of Cerebral Blood Flow and Metabolism

Volumn 36, Issue 1, 2016, Pages 199-203

  Gesierich, Benno ^a   Opherk, Christian ^a,b   Rosand, Jonathan ^c,d   Gonik, Mariya ^a   Malik, Rainer ^a   Jouvent, Eric ^e   Hervé, Dominique ^f   Adib Samii, Poneh ^g   Bevan, Steve ^g   Pianese, Luigi ^h   Silvestri, Serena ^h   Dotti, Maria T ⁱ   De Stefano, Nicola ⁱ   Van Der Grond, Jeroen ^j   Boon, Elles M J ^j   Pescini, Francesca ^k   Rost, Natalia ^c   Pantoni, Leonardo ^k   Lesnik Oberstein, Saskia A ^j   Federico, Antonio ⁱ   Ragno, Michele ^h   Markus, Hugh S ^l   Tournier Lasserve, Elisabeth ^f   Chabriat, Hugues ^e   Dichgans, Martin ^a,m   Duering, Marco ^a   Ewers, Michael ^a   more..

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b SLK Kliniken Heilbronn   (Germany)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^e HÔPITAL LARIBOISIÈRE   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^h Mazzoni Hospital   (Italy)

ⁱ UNIVERSITY OF SIENA   (Italy)

^j LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^k CAREGGI UNIVERSITY HOSPITAL   (Italy)

^l UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^m Technische Universität München Munich Cluster for Systems Neurology   (Germany)

more..

Author keywords

APOE; CADASIL; multicenter study; small vessel disease; white matter hyperintensities

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; NOTCH3 RECEPTOR; ISOPROTEIN;

ADULT; ALLELE; ARTICLE; BRAIN SIZE; CADASIL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; GOOD CLINICAL PRACTICE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK FACTOR; WHITE MATTER; WHITE MATTER HYPERINTENSITY VOLUME; CLINICAL TRIAL; GENE FREQUENCY; GENETICS; GENOME-WIDE ASSOCIATION STUDY; METABOLISM; MIDDLE AGED; PATHOLOGY; REGRESSION ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; APOLIPOPROTEIN E2; CADASIL; FEMALE; GENE FREQUENCY; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN ISOFORMS; REGRESSION ANALYSIS; RISK FACTORS; WHITE MATTER;

EID: 84951569888     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2015.85     Document Type: Article

References (15)

1. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013; 12: 822-838
2. Carmelli D, DeCarli C, Swan GE, Jack LM, Reed T, Wolf PA, et al. Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. Stroke 1998; 29: 1177-1181
3. Schilling S, DeStefano AL, Sachdev PS, Choi SH, Mather KA, DeCarli CD, et al. APOE genotype and MRI markers of cerebrovascular disease: systematic review and metaanalysis. Neurology 2013; 81: 292-300
4. Brickman AM, Zahodne LB, Guzman VA, Narkhede A, Meier IB, Griffith EY, et al. Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence. Neurobiol Aging 2014; 36: 27-32
5. Gurol ME, Viswanathan A, Gidicsin C, Hedden T, Martinez-Ramirez S, Dumas A, et al. Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study. Ann Neurol 2013; 73: 529-536
6. Opherk C, Gonik M, Duering M, Malik R, Jouvent E, Herve D, et al. Genome-wide genotyping demonstrates a polygenic risk score associated with white matter hyperintensity volume in CADASIL. Stroke 2014; 45: 968-972
7. Singhal S, Bevan S, Barrick T, Rich P and Markus HS. The influence of genetic and cardiovascular risk factors on the CADASIL phenotype. Brain 2004; 127: 2031-2038
8. van den Boom R, Lesnick Oberstein SAJ, van den Berg-Huysmans AA, Ferrari MD, van Buchem MA and Haan J. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: structural MR imaging ghanges and apolipoprotein E genotype. Am J Neuroradiol 2006; 27: 359-362
9. Duering M, Zieren N, Herve D, Jouvent E, Reyes S, Peters N, et al. Strategic role of frontal white matter tracts in vascular cognitive impairment: a voxel-based lesion-symptom mapping study in CADASIL. Brain 2011; 134: 2366-2375
10. Nelson PT, Pious NM, Jicha GA, Wilcock DM, Fardo DW, Estus S, et al. APOE-epsilon2 and APOE-epsilon4 correlate with increased amyloid accumulation in cerebral vasculature. J Neuropathol Exp Neurol 2013; 72: 708-715
11. Thal DR, Larionov S, Abramowski D, Wiederhold KH, Van Dooren T, Yamaguchi H, et al. Occurrence and co-localization of amyloid beta-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice. Neurobiol Aging 2007; 28: 1221-1230
12. Carare RO, Hawkes CA, Jeffrey M, Kalaria RN and Weller RO. Review: cerebral amyloid angiopathy, prion angiopathy, CADASIL and the spectrum of protein elimination failure angiopathies (PEFA) in neurodegenerative disease with a focus on therapy. Neuropathol Appl Neurobiol 2013; 39: 593-611
13. Greenberg SM, Vonsattel JP, Segal AZ, Chiu RI, Clatworthy AE, Liao A, et al. Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy. Neurology 1998; 50: 961-965
14. Romero JR, Preis SR, Beiser AS, DeCarli C, Lee DY, Viswanathan A, et al. Lipoprotein phospholipase A2 and cerebral microbleeds in the Framingham Heart Study. Stroke 2012; 43: 3091-3094
15. Wright CB, Moon Y, Paik MC, Brown TR, Rabbani L, Yoshita M, et al. Inflammatory biomarkers of vascular risk as correlates of leukoariosis. Stroke 2009; 40: 3466-3471.